Application of Once-Monthly Self-Reported ACT Questionnaire in Management of Adherence to Inhalers in Outpatients with Asthma

Figures & data

Figure 1 Flowchart of the study design and procedures.

Table 1 Comparison of Patients’ Adherence to Inhalers Between the Two Groups

	Control (%)	Observation (%)
Adherents	24 (7.69)	42 (13.33)*
Intermediate adherents	134 (42.95)	171 (54.29)*
Poor adherents	154 (49.36)	102 (32.38)*
Erratic non-adherents	230 (73.72)	124 (39.37)**
Deliberate non-adherents	157 (50.32)	172 (54.60)
Unwitting non-adherents	119 (38.14)	83 (26.35)*
Total	312	315

Notes: Non-adherents include intermediate and poor adherents, and the non-adherence was subdivided as erratic, deliberate and unwitting patterns. *Compared with control, P < 0.05; **Compared with control, P < 0.01.

Figure 2 TAI results of patients: (A) average scores of items 1–10; (B) patients’ choice on items 11 and 12. *Compared with control, P < 0.05; **compared with control, P < 0.01.

Table 2 Comparison of Lung Function of Patients Between Two Groups (Mean ± SD)

		Control (%)	Observation (%)
FEV1% pred	Before treatment	56.12±13.02	56.05±13.49^a
	After treatment	67.31±11.47^b	76.63±12.64^b, c
	Improvement	19.94±3.47	36.72±7.64^c
PEF % pred	Before treatment	63.15±7.34	63.42±6.72^a
	After treatment	78.21±6.86^b	89.86±7.13^b, c
	Improvement	23.85±2.64	41.69±5.78^c
FVC % pred	Before treatment	78.46±11.07	78.28±11.85^a
	After treatment	84.94±11.45^b	92.63±11.26^b, c
	Improvement	8.26±1.84	18.33±3.16^c

Notes: ^aCompared with control, P>0.05; ^bCompared with that before treatment, P<0.05; ^cCompared with control, P<0.05.

Figure 3 Asthma control evaluated by ACT scores: (A) in the observation group; (B) comparison between control and the observation group after treatment.